The SII can be employed as a potential new biomarker to predict outcomes in APE patients, particularly the occurrence, severity, and mortality of APE.
Keyphrases
- pulmonary embolism
- end stage renal disease
- inferior vena cava
- ejection fraction
- newly diagnosed
- chronic kidney disease
- oxidative stress
- liver failure
- risk assessment
- cardiovascular events
- prognostic factors
- peritoneal dialysis
- drug induced
- respiratory failure
- intensive care unit
- risk factors
- metabolic syndrome
- extracorporeal membrane oxygenation
- aortic dissection
- patient reported